These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 2378175

  • 1. [Comparison of mid- and high dosage methylprednisolone pulse therapy in chronic polyarthritis].
    Schlumpf U, Hofmann P.
    Z Rheumatol; 1990; 49(3):160-4. PubMed ID: 2378175
    [Abstract] [Full Text] [Related]

  • 2. [Treatment with megadoses of dexaven (dexamethasone) versus methypred (6-methylprednisolone) of patients with rheumatoid arthritis].
    Lashina NIu, Solov'ev SK, Balabanova RM.
    Ter Arkh; 2000; 72(5):28-31. PubMed ID: 11109615
    [Abstract] [Full Text] [Related]

  • 3. Methylprednisolone pulse therapy in conjunction with azathioprine in rheumatoid arthritis.
    Bijlsma JW, Schenk Y, Ramselaar AC, Huber-Bruning O.
    Clin Rheumatol; 1986 Dec; 5(4):499-504. PubMed ID: 3816097
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Prognostic value of Sharp's index in the clinical and laboratory response to an intravenous methylprednisolone pulse in patients with rheumatoid arthritis].
    Cuchacovich M, Gatica H, Muñoz S, González P.
    Rev Med Chil; 2000 Mar; 128(3):301-8. PubMed ID: 10962872
    [Abstract] [Full Text] [Related]

  • 6. Pulse methylprednisolone in rheumatoid arthritis: effects on peripheral blood and synovial fluid neutrophil surface phenotype.
    Youssef P, Roberts-Thomson P, Ahern M, Smith M.
    J Rheumatol; 1995 Nov; 22(11):2065-71. PubMed ID: 8596146
    [Abstract] [Full Text] [Related]

  • 7. Effects of high dose methylprednisolone pulse therapy on bone mass and biochemical markers of bone metabolism in patients with active rheumatoid arthritis: a 12-month randomized prospective controlled study.
    Frediani B, Falsetti P, Bisogno S, Baldi F, Acciai C, Filippou G, Bacarelli MR, Filipponi P, Galeazzi M, Marcolongo R.
    J Rheumatol; 2004 Jun; 31(6):1083-7. PubMed ID: 15170918
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Side effects and efficiency of 15 mg and 25 mg methotrexate per week in chronic polyarthritis].
    Schnabel A, Reinhold-Keller E, Willmann V, Dihlmann W, Gross WL.
    Z Rheumatol; 1994 Jun; 53(3):142-9. PubMed ID: 8091868
    [Abstract] [Full Text] [Related]

  • 10. Intravenous pulsed steroids in rheumatoid arthritis: a comparative dose study.
    Iglehart IW, Sutton JD, Bender JC, Shaw RA, Ziminski CM, Holt PA, Hochberg MC, Zizic TM, Engle EW, Stevens MB.
    J Rheumatol; 1990 Feb; 17(2):159-62. PubMed ID: 2319516
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Use of pulsed steroid therapy in active rheumatoid arthritis].
    Pavelka K, Honzlová M, Vencovský J.
    Cas Lek Cesk; 1992 Oct 09; 131(19):593-9. PubMed ID: 1464075
    [Abstract] [Full Text] [Related]

  • 14. [FDDF (fast dissolving dosage form) piroxicam for sublingual administration in the treatment of rheumatoid arthritis].
    Montecucco C, Caporali R, Ronchetti A, Rossi S, Comaschi E.
    Minerva Med; 1994 Dec 09; 85(12):633-8. PubMed ID: 7854556
    [Abstract] [Full Text] [Related]

  • 15. [Experience with long term low dose methotrexate treatment in rheumatoid arthritis and arthritic psoriasis].
    Náfrádi L, Varga L.
    Orv Hetil; 1995 Jul 16; 136(29):1555-7. PubMed ID: 7637973
    [Abstract] [Full Text] [Related]

  • 16. [The importance of administration of a series of methylprednisolone minipulses in the treatment of active rheumatoid arthritis].
    Hrncír Z.
    Cas Lek Cesk; 1994 Jul 18; 133(14):440-2. PubMed ID: 8069902
    [Abstract] [Full Text] [Related]

  • 17. Polyarticular corticosteroid injection versus systemic administration in treatment of rheumatoid arthritis patients: a randomized controlled study.
    Furtado RN, Oliveira LM, Natour J.
    J Rheumatol; 2005 Sep 18; 32(9):1691-8. PubMed ID: 16142862
    [Abstract] [Full Text] [Related]

  • 18. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM, Keen HI, Stamp LK, Lee AT, Goldblatt F, Ayres OC, Rischmueller M, James MJ, Hill CL, Caughey GE, Cleland LG.
    Semin Arthritis Rheum; 2007 Oct 18; 37(2):99-111. PubMed ID: 17391739
    [Abstract] [Full Text] [Related]

  • 19. Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.
    Shergy WJ, Isern RA, Cooley DA, Harshbarger JL, Huffstutter JE, Hughes GM, Spencer-Smith EA, Goldman AL, Roth SH, Toder JS, Warner D, Quinn A, Keenan GF, Schaible TF, PROMPT Study Group. Profiling Remicade Onset with MTX in a Prospective Trial.
    J Rheumatol; 2002 Apr 18; 29(4):667-77. PubMed ID: 11950005
    [Abstract] [Full Text] [Related]

  • 20. [Clinical effectiveness and tolerance of auranofin in patients with chronic polyarthritis. Results of a multicenter long-term study].
    Klein G, Schwann H, Mirtl B, Thumb N, Mayerhofer F, Singer F, Tausch G, Gaismayer K, Rieder H, Hartweger A.
    Z Rheumatol; 1988 Apr 18; 47(5):342-6. PubMed ID: 3149087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.